RESUMO
BACKGROUND: The etiology of Parkinson's disease (PD) is not well known and there is increasing evidence that oxidative stress also plays an important role in its pathogenesis. Salusins alpha (salusin-α) and beta (salusin-ß) affect the central nervous system, vasculature, and kidneys to increase the inflammatory response in endothelial cells, stimulate oxidative stress, and increase monocyte-endothelial adhesion. Neuroinflammation and oxidative stress play roles in the etiopathogenesis of PD. PURPOSE: To investigate whether salusin-α and -ß are related to PD and whether they are correlated with the development of atherosclerosis, body mass index, disease duration, and the Parkinson's Hoehn and Yahr stage. RESULTS: The low-density lipoprotein cholesterol (LDL-C), total cholesterol, and salusin-ß levels were significantly lower and age was significantly higher in Parkinson patients compared to healthy controls (ρ < 0.005). We found a negative linear correlation between salusin-ß and the Hoehn and Yahr stage (ρ < 0.001, r = -0.515) in the patients. CONCLUSIONS: There was a relationship between salusin-ß and PD and a correlation between the salusin-ß levels and Parkinson's stage. A possible underlying disease mechanism is an increase in oxidative stress and decrease in neuroprotective effects due to low salusin-ß levels. Therefore, the effects of salusin-ß in treating Parkinson disease should be evaluated. Further studies are needed to understand the effects of salusin-ß treatment on preventing or slowing the course of PD.
